日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CD4(+) T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapy.

CD4(+) T 细胞介导 BCMA CAR-T 细胞治疗后 CAR-T 细胞相关的免疫相关不良事件。

Ho Matthew, Paruzzo Luca, Noll Julia Han, Stella Federico, Devi Pooja, Ndeupen Sonia, Day Yael A, Chen Gregory M, Cohen Ivan J, Ramirez-Fernandez Angel, Waxman Adam, Kapur Shivani, Chen Fang, Xu Rong, Huff Andrew, Jarocha Danuta, Patel Vrutti, Bochi-Layec Audrey C, Ramasubramanian Ranjani, Liu Shan, Bouvier Riemke, de Souza Vitor B, Patel Heta, Li Ziyu, Carturan Alberto, Michener Peter, Hopkins Caitlin R, Koucky Owen, Minehart Janna, Dimitri Alex, Nabar Neel R, Hasanali Zainul S, Ciccarelli Bryan T, Hung Putzer, Williams Erik, Bartoszek Robert, Lavorando Maya, Mohan Suyash, Gonzalez Vanessa E, Porazzi Patrizia, Bhoj Vijay G, Apostolidis Sokratis A, Vogl Dan T, Porter David L, Scholler John, Diorio Caroline, Roche Aoife M, Everett John K, Bushman Frederic D, Nathanson Katherine L, Stadtmauer Edward A, Susanibar-Adaniya Sandra P, Garfall Alfred L, Ruella Marco, Cohen Adam D, Fraietta Joseph A

Immune effector cell-associated enterocolitis post-BCMA directed CAR T-cell therapy: insights from a multicenter case series

BCMA靶向CAR-T细胞治疗后免疫效应细胞相关性肠炎:来自多中心病例系列的启示

Susanibar-Adaniya, Sandra; Derman, Benjamin A; Cohen, Adam D; Vogl, Dan T; Richard, Shambavi; Rossi, Adriana; Frigualt, Matthew J; Yee, Andrew J; Dhakal, Binod; Bar, Noffar

Outcomes of radiation integrated with T-cell-engaging bispecific antibodies in relapsed/refractory multiple myeloma

放射治疗联合T细胞结合双特异性抗体治疗复发/难治性多发性骨髓瘤的疗效

Patel, Heta; Hubbeling, Harper; Yu, Kyle; Carpenter, Maribel; LaRiviere, Michael J; Plastaras, John P; Cohen, Adam D; Kapur, Shivani; Vogl, Dan T; Waxman, Adam J; Stadtmauer, Edward A; Garfall, Alfred L; Susanibar-Adaniya, Sandra

When Timing Matters Most: Early Relapse Outweighs Baseline Risk in Myeloma

时机至关重要:多发性骨髓瘤早期复发风险高于基线风险

Shan, Xinhe; Susanibar-Adaniya, Sandra P

Outcomes of elderly patients with relapsed refractory multiple myeloma (RRMM) treated with teclistamab: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium

接受teclistamab治疗的复发难治性多发性骨髓瘤(RRMM)老年患者的疗效:美国多发性骨髓瘤免疫治疗联盟的一项多中心研究

Pasvolsky, Oren; Dima, Danai; Feng, Lei; Dong, Wenli; Richards, Tiffany; Davis, James A; Afrough, Aimaz; Vazquez-Martinez, Mariola; Sannareddy, Aishwarya; Goel, Utkarsh; Banerjee, Rahul; Khouri, Jack; Cervoni, Frances; Gaballa, Mahmoud R; Lieberman-Cribbin, Alex; Rana, Masooma Shifa; Julian, Kelley; Ferreri, Christopher J; Shune, Leyla; DeJarnette, Shaun; Bhurtel, Evguenia; Susanibar Adaniya, Sandra; Portuguese, Andrew; Hosoya, Hitomi; Mikkilineni, Lekha; Kaur, Gurbakhash; Rossi, Adriana; Herr, Megan M; Schrum, Daniel; Lin, Chenyu; Raza, Shahzad; Lin, Yi; Midha, Shonali; Omar, Nadeem; Atarsh, Shebli; McGuirk, Joseph; Sborov, Douglas; Voorhees, Peter; Anwer, Faiz; Alsina, Melissa; Freeman, Ciara; Garfall, Alfred L; Razzo, Beatrice M; Sidana, Surbhi; Cowan, Andrew J; Anderson, Larry D Jr; Hansen, Doris K; Richard, Shambavi; Patel, Krina K; Lee, Hans C; Grajales-Cruz, Ariel

Outcomes of relapse after teclistamab therapy in multiple myeloma

多发性骨髓瘤患者接受teclistamab治疗后复发的结局

Yu, Kyle L; Ho, Matthew; Paruzzo, Luca; Stella, Federico; Patel, Heta; Hasanali, Zainul S; Kapur, Shivani; Waxman, Adam J; Vogl, Dan T; Stadtmauer, Edward A; Fraietta, Joseph A; Ruella, Marco; Cohen, Adam D; Garfall, Alfred L; Susanibar-Adaniya, Sandra

The impact of extramedullary and paraskeletal plasmacytomas on treatment outcomes in multiple myeloma treated with teclistamab: U.S. Myeloma Immunotherapy Consortium real-world experience

髓外和骨旁浆细胞瘤对接受teclistamab治疗的多发性骨髓瘤患者治疗结果的影响:美国骨髓瘤免疫治疗联盟的真实世界经验

Afrough, Aimaz; Dima, Danai; Razzo, Beatrice; Goel, Utkarsh; Sannareddy, Aishwarya; Pasvolsky, Oren; Vazquez-Martinez, Mariola A; Ferreri, Christopher J; Banerjee, Rahul; Khouri, Jack; Davis, James A; Gaballa, Mahmoud R; Lieberman-Cribbin, Alex; Rana, Masooma S; Julian, Kelley; Anwer, Faiz; Shune, Leyla; DeJarnette, Shaun; Grajales-Cruz, Ariel F; Ouchveridze, Evguenia; De Avila, Gabriel; Susanibar-Adaniya, Sandra P; Portuguese, Andrew J; Schrum, Daniel; Eberwein, Erin; Hosoya, Hitomi; Mikkilineni, Lekha; Kaur, Gurbakhash; McGuirk, Joseph P; Rossi, Adriana; Herr, Megan M; Castaneda, Omar; Locke, Frederick L; Raza, Shahzad; Lin, Yi; Atrash, Shebli; Sborov, Douglas W; Voorhees, Peter M; Richard, Shambavi; Garfall, Alfred L; Sidana, Surbhi; Patel, Krina K; Hansen, Doris K; Cowan, Andrew J; Anderson, Larry D Jr; Lee, Hans C

Association of age, race, and ethnicity with access, response, and toxicities from CAR-T therapy in children and adults with B-cell malignancies: a review

年龄、种族和民族与儿童和成人B细胞恶性肿瘤患者接受CAR-T疗法的机会、疗效和毒性之间的关联:一项综述

Ghilardi, Guido; Hasanali, Zainul S; Susanibar-Adaniya, Sandra P; Winestone, Lena E; Ruella, Marco; Garfall, Alfred L

Non-tuberculous mycobacterial infections following teclistamab in multiple myeloma

多发性骨髓瘤患者接受teclistamab治疗后发生非结核分枝杆菌感染

Ho, Matthew; Paruzzo, Luca; Minehart, Janna; Voruganti, Teja; Devi, Pooja; Vogl, Dan T; Cohen, Adam D; Garfall, Alfred L; Waxman, Adam J; Kapur, Shivani; Stadtmauer, Edward A; Adaniya, Sandra Susanibar; Longworth, Sarah

Age-related disparities in treatment and outcomes for newly diagnosed multiple myeloma: a population-based study

新诊断多发性骨髓瘤患者治疗和预后中与年龄相关的差异:一项基于人群的研究

Shan, Xinhe; Kuiper, Rowan; Ding, Chuling; Munshi, Pashna N; Stadtmauer, Edward A; Susanibar-Adaniya, Sandra P